Poly Medicure Ltd

Poly Medicure Earnings Call: Key Takeaways

Poly Medicure delivered strong FY26 performance with 12.3% consolidated revenue growth and significant gross margin expansion. Strategy focuses on high-end tech segments through Citieffe and PendraCare acquisitions.

Poly Medicure Q4 FY26 Results: Net Profit ₹65 Cr, Down 29.2% YoY

Poly Medicure Ltd reported revenue from operations of ₹534.5 Cr (+21.3% YoY) and net profit of ₹65 Cr (-29.2% YoY) for Q4 FY26.

Key figure

Net profit ₹65 Cr · -29.2% YoY

Poly Medicure Financial Results

Poly Medicure Limited reported audited financial results for FY2025-26 and recommended a Rs 3.5 dividend per share. The board also re-appointed internal auditors for the next year.

Value

₹3.50 Cr

Poly Medicure Employee Stock Options

Poly Medicure granted 17,500 stock options at ₹100 per share under its 2020 ESOP scheme. The options vest over four years, aligning employee and shareholder interests.

Value

₹0.18 Cr

Execution

Vesting over 4 years

Poly Medicure Board Meeting Date

Poly Medicure scheduled a board meeting on May 25, 2026. The board will consider audited financial results and a potential final dividend recommendation.